Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Variant Specific Periostin Neutralization for Diabetic Retinopathy
Fragmentation of RANKL Eliminates Side-effect while Boosting Effect.
Investment / Co-development Opportunity for Start-up Company